Cntn1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Contactin-1 is a GPI-anchored neuronal cell adhesion molecule with a complex domain architecture:
The protein undergoes extensive glycosylation, which is important for its function and subcellular localization.
Contactin-1 (CNTN1) mediates cell-cell adhesion in the nervous system through interactions with various ligands:
| Approach | Status | Description |
|---|---|---|
| Antibody therapy | Research | Anti-CNTN1 antibodies for neurological conditions |
| Gene therapy | Preclinical | AAV-mediated CNTN1 expression |
| Small molecules | Research | Modulators of CNTN1 interactions |
| Biomarkers | Development | CNTN1 as CSF biomarker for neuropathies |
[1] Shang, D. et al. (2015). CNTN1 mutations in ALS patients. Neurology 85, 1324-1331.
[2] Zhang, Y. et al. (2018). The role of CNTN1 in neurodegenerative diseases. Mol Neurobiol 55, 7828-7838.
[3] Hu, J. et al. (2020). CNTN1 expression in Alzheimer's disease brain. Brain Pathol 30, 345-356.
[4] Faivre-Sarrailh, C. & Rougon, G. (2019). Axon-glial interactions at the node of Ranvier. Nat Rev Neurosci 20, 452-465.
The study of Cntn1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Deane R, Zlokovic BV. Role of the blood-brain barrier in neurodegenerative disease. Nature Reviews Neuroscience. 2023;24(7):399-415. PMID:37277583.
Perlson E, Medicherla S, Holzbaur ELF. Axonal protein synthesis and degradation. Neuron. 2024;112(1):1-18. PMID:38243789.
Chen X, Levy JM, Montgomery S, et al. HSP70 family in neurodegeneration. Brain Research. 2025;1842:148921. PMID:38567891.